Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya (R) (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Athletes recognized the performance-enhancing potential of human growth hormone when it became available for treatment of short stature in growth-retarded children. Although no controlled clinical ...

FDA expands Sogroya approval for pediatric patients with Noonan syndrome, idiopathic short stature, and those born small for gestational age.

Launched By Crazy Bulk' Steroids Alternatives for Cutting, Bulking, Body Building & Muscle Growth Safe Oral Steroids For ...

Novo Nordisk today announced that the US Food and Drug Administration (FDA) has approved three new indications for once-weekly Sogroya® (somapacitan-beco) injection 5 mg, 10 mg, or 15 mg, a ...

Vice President, Investor Relations at Ascendis Pharma A/S. Joining me on the call today are Jan Moller Mikkelsen, President ...

Another older, small study of 32 older adults found that MK-677 boosted levels of growth hormone in participants to a level ...

In the weeks before the just-completed Games in London, those testers buzzed about a brand-new test they'd developed to track down athletes who take human growth hormone. David Howman, the director ...

For the second-straight season, one of Atlanta's key hitters received a suspension from MLB.

The compounds have exploded in popularity, but big questions about safety and effectiveness are still unresolved.

Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are ...

Novo Nordisk offers market opportunities through its focus on digital transformation, innovation in biological medicines for diabetes, obesity, and rare diseases, and global outreach via its brands ...